Intellectual Property India Publishes Patent Application for 'Transgenic Animals Expressing Chimeric C-Kit Protein' Filed by Jasper Therapeutics, Inc.

MUMBAI, India, Feb. 21 -- Intellectual Property India has published a patent application (202517000481 A) filed by Jasper Therapeutics, Inc., Redwood City, U.S.A., on Jan. 2, for 'transgenic animals expressing chimeric c-kit protein.'

Inventor(s) include Pang, Wendy.

The application for the patent was published on Feb. 21, under issue no. 08/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure describes methods of generating a transgenic cell or mouse that expresses a chimeric c-KIT protein capable of expression on mouse cells and binding to mouse stem cell factor (SCF) which can be inhibited by anti-human c-KIT inhibitors. The transgenic cells and mice can be used to test candidate anti-hu...